- 专利标题： Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
-
申请号： US12970632申请日： 2010-12-16
-
公开(公告)号： US08178530B2公开(公告)日： 2012-05-15
- 发明人: Martin James Inglis Andrews , Paul Edwards , Reginald Christophe Xavier Brys , Philip Huxley , Wolfgang Schmidt , Veronique Birault , Mark Stuart Chambers , Clifford John Harris , Angus MacLeod , Kim Louise Hirst , Juha Andrew Clase , Gregory Bar
- 申请人： Martin James Inglis Andrews , Paul Edwards , Reginald Christophe Xavier Brys , Philip Huxley , Wolfgang Schmidt , Veronique Birault , Mark Stuart Chambers , Clifford John Harris , Angus MacLeod , Kim Louise Hirst , Juha Andrew Clase , Gregory Bar
- 申请人地址： BE Beerse
- 专利权人： Janssen Pharmaceutica NV
- 当前专利权人： Janssen Pharmaceutica NV
- 当前专利权人地址： BE Beerse
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61K31/4985
摘要：
Novel imidazo[1,2-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.
公开/授权文献
信息查询
